Press release
Creative Biolabs Upgrades Oncolytic Virus Product List for Immunotherapy Research
As early as around 1800, doctors discovered that certain cancer patients would have their symptoms reduced after being briefly infected with viruses. With the advancement of genetic engineering technology, the idea that viruses have the potential to improve and mediate immunotherapy has been established. Oncolytic viruses (OVs) are such kind of viruses that can replicate in tumor tissues, and kill tumor cells. Up to now, two OV drugs have been marketed globally, and many more are still in the research and development stage.Empowered by leading technology and years of experience in biomedical science, Creative Biolabs has integrated a package of premade OV products, covering the most researched type of genetically-engineered adenovirus (AdV), vesicular stomatitis virus (VSV), herpes simplex virus (HSV), and vaccinia virus (VACV), to facilitate related research on treatment of melanoma, prostate cancer, breast cancer, ovarian cancer, and others.
· Reporter-encoding Oncolytic Virus
Reporter-encoding oncolytic viruses allow accurate tracking of gene expression, tumor metastases, viral infection, and assessment of gene therapy. Creative Biolabs has released a series of purified reporter-encoding OVs, including herpes simplex virus and vaccinia virus.
Featured products:
Reporter-encoding Oncolytic Herpes Simplex Virus 1 (ΔICP34.5, ΔUNG), SV40-GFP
Reporter-encoding Oncolytic Herpes Simplex Virus 1 (ΔICP27), CMV-Dsred
Reporter-encoding Oncolytic Herpes Simplex Virus 1 (ΔICP27), CMV-luciferase
· Cytokine-expressing Oncolytic Virus
Research has shown that the oncolytic efficacy of OVs can be enhanced through the expression of therapeutic transgenes like cytokines. Creative Biolabs has built an advanced OV engineering platform which provides a series of purified cytokine-expressing OV products.
Featured products:
Cytokine-expressing Oncolytic Herpes Simplex Virus 1 (ΔΔICP0), CMV-IL-15
Cytokine-expressing Oncolytic Vaccinia Virus Western Reserve (ΔE3L), pSE/L-mLIGHT
Cytokine-expressing Oncolytic Herpes Simplex Virus 1 (ΔICP27), CMV-CCL17
Besides, the product portfolio also ranges from immune checkpoint antibody-armed OVs, capsid-modified OVs, miRNA-regulated OVs to oncolytic adenovirus construction kits. Creative Biolabs ensures accurate design and construction, and manifold functional validations, and if there are any specific demands, the scientist team will help design customized products with timely delivery.
Detailed information about OV-related services, and products at Creative Biolabs can be found on https://www.creative-biolabs.com/oncolytic-virus.
About Creative Biolabs
Empowered by leading technology and years of experience in biomedical science, Creative Biolabs is dedicated to offering comprehensive, end-to-end oncolytic virus therapy development services to support novel therapeutics development. The whole pipeline covers oncolytic virus engineering, construction, in vitro validation study, in vivo preclinical study, disease-specific oncolytic virotherapy development, and oncolytic virotherapy development for combination therapy with cancer immunotherapy.
New York, USA
About Creative Biolabs
Empowered by leading technology and years of experience in biomedical science, Creative Biolabs is dedicated to offering comprehensive, end-to-end oncolytic virus therapy development services to support novel therapeutics development. The whole pipeline covers oncolytic virus engineering, construction, in vitro validation study, in vivo preclinical study, disease-specific oncolytic virotherapy development, and oncolytic virotherapy development for combination therapy with cancer immunotherapy.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Creative Biolabs Upgrades Oncolytic Virus Product List for Immunotherapy Research here
News-ID: 2291883 • Views: …
More Releases from Creative Biolabs
Exosome Display Technology for Antibody Generation, Targeted Delivery, and Prote …
Scientists now have realized that exosomes, representing a novel mode of intercellular communication, contribute to a wide range of biological processes in health and disease including cancer. Especially, growing evidence shows that tumor-derived exosomes play critical roles in cancer. Exosomes and their cargos may serve as cancer prognostic markers, therapeutic targets or even as anticancer drug‐carrier.
Exosome display is an innovative methodology enabling the manipulation of exosome protein content by the…
Exosomes News: Creative Biolabs Introduces Exosome Purification Services for Car …
As exosomes can transmit the information of donor cells to recipient cells through the proteins, mRNA, miRNA carried by them, thus to realize the information and material exchange between cells, they have been a hot topic recently as being used as a drug carrier to transport drugs.
"Future research may focus on how to improve the cargo loading of exosomes," said the senior scientist from Creative Biolabs, “at present, some…
Novel Strategies to Accelerate Research on Antibodies Against Exosomal Markers
Exosome, with a lipid bilayer membrane structure, is a tiny membrane vesicle that can be secreted by most cells. As a new research hotspot, exosomes have become a potentially effective method for disease diagnosis and treatment due to their wide existence in the body and convenient access, and have shown great potential in exosomal cargo loading and targeted delivery. Additionally, research on exosome antibodies may contribute to shaping the future…
More Releases for Oncolytic
Oncolytic Virus Market: Know Applications Supporting Impressive Growth
A new business intelligence report released by HTF MI with title "Global Oncolytic Virus Market Professional Survey Report 2019" is designed covering micro level of analysis by manufacturers and key business segments. The Global Oncolytic Virus Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative…
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Prologue to Oncolytic Virus
1.1 Outline of Oncolytic Virotherapy
1.2 Trail from Genesis to Biogenetics
Primer of Virotherapy in Malignancies
2.1 Oncolytic Viruses towards Cancer
2.2 Approaches for Targeting Tumor Cells
2.2.1 Pro Apoptotic Targeting
2.2.2 Translational Targeting
2.2.3 Transcriptional Targeting
2.2.4 Transductional Targeting
Mechanism…
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic…
Global Oncolytic Virus Therapy Market & Oncolytic Virus clinical Trials Outlook …
Advancements in human genomics over the last two decades have shown that cancer is mediated by somatic aberration in the host genome. This discovery has incited enthusiasm among cancer researchers; many now use therapeutic approaches in genetic manipulation to improve cancer regression and find a potential cure for the disease.
The dominant cancer treatment modalities such as chemotherapy, radiotherapy, and even targeted kinase inhibitors and mAbs are limited by low…
Global Oncolytic Virus Therapy Pipeline Analysis
Though still in nascent stages, Oncolytic viruses have shown immense opportunities and potential to be tapped in the future to improve the treatment of cancer and the lives of the patients. Immunotherapy, the umbrella for Oncolytic viruses would not offer cures, but survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the most important approach to treat…
Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic…
